Hospira, Inc.

Form 483 issued September 20, 2024 · Austin, Texas

Inspection
Sep 9 – Sep 20, 2024
Observations
10
Pages
25
FEI number
1628454

In short: On September 20, 2024, FDA issued a Form 483 with 10 observations to Hospira, Inc. in Austin, Texas (FEI 1628454) after an inspection that ran Sep 9 – Sep 20, 2024. The investigators were Miguel A. Martinez and Santos E. Camara. Most observations concern laboratory controls and quality system; the most-cited regulation is 21 CFR 211.160 (general requirements).

At a glance

Laboratory controls and quality system account for 6 of 10 observations.

Laboratory controls4
Quality system2
Production2
Materials1
Other1

Most cited: 21 CFR 211.160 (3×) · 211.166 (2×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    The responsibilities and procedures applicable to the quality control unit…

  2. 02

    The written stability testing…

  3. 03

    The written stability program for drug products does not include test intervals based on statistical criteria…

  4. 04

    Procedures designed to prevent microbiological contamination of drug products purporting to be sterile are not…

6 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Hospira, Inc.?

FDA listed 10 observations on this Form 483, mostly about laboratory controls, quality system and production. The most-cited regulation is 21 CFR 211.160 (general requirements). The opening words of each observation are shown on this page.

Who inspected Hospira, Inc.?

Miguel A. Martinez and Santos E. Camara are named on this Form 483, for the inspection of Sep 9 – Sep 20, 2024. Each investigator has a profile showing what they cite most.

When was Hospira, Inc. inspected by FDA?

The inspection ran Sep 9 – Sep 20, 2024, and the Form 483 is dated September 20, 2024.

How do I get the full Form 483 for Hospira, Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free